STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren’s Syndrome: Association with Disease Susceptibility and Clinical Aspects
Table 1
Clinical and laboratory data of the 195 SS patients.
Clinical features
Sex (M/F)
9/186
Age ( deviation, years)
Age at diagnosis ( deviation, years)
Xerophthalmia
179/195 (91.7%)
Xerostomia
174/195 (89.2%)
Salivary gland swelling
44/195 (22.5%)
Arthritis
22/195 (11.2%)
Lymphoma
9/195 (4.6%)
Laboratory features
ANA
168/195 (86.1%)
Anti-SSA
126/195 (64.6%)
Anti-SSB
86/195 (44.1%)
Hypergammaglobulinemia
67/195 (34.3%)
Rheumatoid factor
67/195 (34.3%)
Leukopenia
44/195 (22.5%)
Hypocomplementemia
21/195 (10.7%)
Monoclonal component
16/195 (8.2%)
Cryoglobulins
8/195 (4.1%)
ANA were considered positive if ; anti-SSA, anti-SSB, and RF were considered positive according to the cut-off of the reference laboratory; hypergammaglobulinemia was diagnosed if total of total proteins; leukopenia was diagnosed if ; hypocomplementemia was diagnosed if and/or .
